baber/WOPTO huggingface dataset:
Patent DE-69712318-T2 (DE)
Inventor: BURTSCHER GUNTHER
IPC: A21C5/00
Filed: 1997-01-15
Granted: 2002-12-05
Abstract: The invention provides and apparatus for scaling and molding dough which comprises a hopper for the dough and a scaling and molding station which is in flow communication with the hopper so that a portion of the dough can be moved from the hopper to the scaling and molding station. The scaling and molding station has at least one aperture forming assembly at its exit which operates to mold the dough portion by rolling it along its internal walls and to pinch off and eject a dough piece from the apparatus. Preferably, the scaling and molding station has a plurality of stacked aperture forming assemblies which function sequentially. The apparatus may be configured to produce several molded dough pieces simultaneously.
Patent DE-69733086-T2 (DE)
Inventor: MUNDEN W
IPC: A61P31/04
Filed: 1997-10-27
Granted: 2006-04-06
Abstract: The present invention provides pharmaceutical compositions comprising an effective amount of dermopharmaceutical active agent, kukui nut oil and a pharmaceutically acceptable base which comprises ingredients selected from the group consisting of propylene glycol, glycerin, xanthin gum, methyl paraben, propyl paraben, stearic acid, menthyl lactate, cetearyl alcohol (and) ceteareth 20, polyoxyl 40 stearate, glyceryl stearate (and) PEG-100 stearate, isopropyl myristate, isopropyl alcohol, oleyl alcohol, oleic acid, dimethicone, or C12-C15 alcohols benzoate and purified water. The inclusion of kukui nut oil acts in synergy as an adjunct to the therapeutic agent to promote the alleviation of the medical condition being treated.
Patent DE-69736597-T2 (DE)
Inventor: FOX M
IPC: A61K31/00
Filed: 1997-04-15
Granted: 2006-12-21
Abstract: The present invention relates to glial cell line-derived neurotrophic factor (GDNF), a potent neurotrophin that exhibits a broad spectrum of biological activities on a variety of cell types from both the central and peripheral nervous systems. The present invention involves the cloning and characterization of a high affinity receptor for GDNF. This molecule has been named GDNF receptor (GDNFR) since it is the first known component of a receptor system. Nucleic acid and amino acid sequences are described for GDNFR protein products. A hydrophobic domain with the features of a signal peptide is found at the amino terminus, while a second hydrophobic domain at the carboxy terminus is involved in the linkage of the receptor to the cell membrane. The lack of a transmembrane domain and cytoplasmic region indicates that GDNFR requires one or more accessory molecules in order to mediate transmembrane signaling. GDNFR mRNA is widely distributed in both nervous system and non-neural tissues, consistent with the similar distribution found for GDNF.
Patent DE-69736682-T2 (DE)
Inventor: LEMKE TIMOTHY A
IPC: H01R12/71
Filed: 1997-10-10
Granted: 2007-09-13
Abstract: Electrical connectors capable of being mounted on circuit substrates by BGA techniques are disclosed. Also disclosed is a method for manufacturing such connectors. There is at least one recess (20,22,24,26,28) on the exterior side of the connector elements. A conductive contact (16) extends from adjacent the interior side of the into the recess on the exterior side of the housing. A controlled volume of solder paste is introduced into the recess. A fusible conductive element, in the form of solder balls (82,100) is positioned in the recess. The connector is subjected to a reflow process to fuse the solder ball (82,100) to the portion of the contact extending into said recess. Contacts (66) are secured in the insulative housing of the connector by deformable sections that minimize stress imposed on the housing, thereby reducing warpage. Solder resist areas are formed on central portions of the contacts to promote uniformity of solder volume. As a result of these features, substantial coplanarity of the BGA array along the mounting interface of the connector is achieved.
Patent DE-69737969-T2 (DE)
Inventor: STEINMAN LAWRENCE
IPC: A61K31/00
Filed: 1997-02-24
Granted: 2008-04-24
Abstract: A pro-inflammatory T response is specifically prevented by the injection into a recipient of DNA encoding the variable region of a T cell receptor. In response to the vaccination, T cells expressing the variable region produce Th2 cytokines, including IL-4. A pro-inflammatory T cell response directed to an autoantigen is shown to be suppressed by DNA vaccination. The suppressive vaccination further reduced the inflammatory effect of T cells reactive against epitopes of the autoantigen not recognized by the variable region used for vaccination.
Patent DE-69806577-T2 (DE)
Inventor: ODDS CHRISTOPHER
IPC: A01N33/12
Filed: 1998-04-07
Granted: 2004-03-04
Abstract: The invention relates to compositions such as body and hair cleansing products, in particular shampoos, comprising one or more antifungals inhibiting fungal ergosterol biosynthesis as a first active ingredient and 10 @ -undecen-3-oyl-aminopropyl trimethylammonium methylsulfate as a second active ingredient.
Patent DE-69807238-T2 (DE)
Inventor: DE ROUFFIGNAC ERIC SHELL EXPLO
IPC: E02D3/11
Filed: 1998-06-03
Granted: 2003-01-02
Abstract: A method is provided to remove volatile liquid contaminates from a contaminated volume of earth, the contaminated volume lying above a noncontaminated layer of earth, the method including the steps of: penetrating the contaminated volume with at least one wellbore so that a wellbore penetrates the contaminated volume and at least one wellbore penetrates the noncontaminated layer; applying heat from the wellbore within the noncontaminated layer to the noncontaminated layer until the temperature of a substantial portion of the noncontaminated layer that is contiguous with the contaminated layer is at least the boiling point temperature of contaminated liquids; and applying heat from the wellbore within the contaminated volume to the contaminated volume wherein the temperature of the contaminated volume rises to the boiling point of contaminated liquids after a substantial portion of the noncontaminated layer that is contiguous with the contaminated layer is about the boiling point of the contaminated liquids.
Patent DE-69808639-T2 (DE)
Inventor: LAST LAURENS
IPC: B65D47/28
Filed: 1998-07-07
Granted: 2003-08-07
Abstract: Connector assembly for a fluid connection, comprising a female part (1), a male part (2) to be connected thereto, and a plug (3). The female part has a body containing an axial bore (7) which extends from an insert opening (4) for the male part through the body. The female part (1) also has a seat (9), extending around the bore, for the plug, which serves to close off the bore. The male part has an internal axial passage for passage of the fluid and a closing member located in the axial passage, whereby the plug is removed from its seat when the male part is inserted into the bore. The closing member has a flexible ring wall, which rests under prestress against the wall of the axial passage and can spring radially inward so as to provide a passage for the fluid.
Patent DE-69808911-T2 (DE)
Inventor: SAETTONE FABRIZIO
IPC: A61K47/48
Filed: 1998-07-22
Granted: 2003-06-12
Abstract: A process for solubilizing in water and in aqueous vehicles sparingly water-soluble pharmaceutically active substances, comprising the following operations: 1) forming a complex of the pharmaceutically active substance with a pharmaceutically acceptable non-ionic polymer capable of forming complexes with the substance, and isolating the complex in solid form; 2) dissolving again the thus obtained complex in an aqueous medium by means of a pharmaceutically acceptable surfactant. The method allows to markedly increase the water-solubility of pharmaceutically active organic compounds which are intrinsically poorly or negligibly soluble in water, in order to obtain preparations that are stable in aqueous solution and contain therapeutically and commercially useful concentrations of active ingredient.
Patent DE-69819696-T2 (DE)
Inventor: CORDELL BARBARA
IPC: G01N33/15
Filed: 1998-03-19
Granted: 2004-09-16
Abstract: The present invention provides methods that can be used to identify beta-amyloid reducing compounds. The present invention is based on the use of organotypic brain slice culturing methods to simultaneously assess the toxicity and beta-amyloid reducing activity of a test compound.
Patent DE-69819880-T2 (DE)
Inventor: HOLMAN J
IPC: A61M25/10
Filed: 1998-03-05
Granted: 2004-11-04
Abstract: A medical device has a catheter with a proximal portion, a distal portion, a shaft and an expandable member located at the distal portion. The expandable member is constructed and arranged for expanding the outer diameter of the catheter from a contracted state to an expanded state. A removable sleeve is positioned around the entire length of the expandable member. The sleeve has a first end and a second end, and an inner diameter that increases over the entire length of the sleeve.
Patent DE-69825741-T2 (DE)
Inventor: TRIEBEL FREDERIC
IPC: C12N1/15
Filed: 1998-06-03
Granted: 2005-09-01
Abstract: This invention concerns an isolated nucleotidic sequence selected from the group consisting of :   a) the nucleotidic sequences SEQ ID N DEG  1, SEQ ID N DEG 3 or SEQ ID N DEG 5 ; b) the nucleotidic sequences which hybridize under stringent conditions to any of the sequences defined in a) and which code for a polypeptide which is a variant of the LAG-3 molecule ; c) the nucleotidic sequences which are degenerated as results of the genetic code to the nucleotidic sequences defined in a) and b), and which code for a polypeptide which is a genetic variant of the LAG-3 molecule.
Patent DE-69829317-T2 (DE)
Inventor: KIKUCHI C
IPC: C07D498/04
Filed: 1998-12-22
Granted: 2006-04-06
Abstract: This invention creates compounds represented by the following formula (1) which, alone or as a plurality of them simultaneously, act upon serotonin receptors, and thereby provides pharmaceutical compositions that contain these compounds and are useful for the treatment or prevention of diseases which are considered to be induced by the abnormality of central and peripheral serotonin controlling functions. <CHEM>   In the formula, R<1> is a hydrogen atom, a lower alkyl group or an aralkyl group; R<2> is a hydrogen atom or a specified substituent; n is an integer of 2 to 6; and  alpha  is the following formula (a), (b), (c), (d) or (e). <CHEM>   In formulae (a) and (b), R<3> is a hydrogen atom or a specified substituent; X is NR<10>, NCONR<11>R<12>, S, SO, SO2 or O; R<10> is a hydrogen atom or a specified substituent; R<11> and R<12> is independently a hydrogen atom or a lower alkyl; Y is a methylene group or a carbonyl group. In formula (c), R<4> is a hydrogen atom or a specified substituent; R<5> is a hydrogen atom or a specified substituent; k is 0 or an integer of 1 to 3; m is 0 or an integer of 1 to 3; each of A and B is a group which forms a specified ring via a double bond; k + m is an integer of 1 to 3. In formulae (d) and (e), R<4> is as defined above; G is CH2, S, O or C=O; D is CH or N; p is an integer of 1 to 3; each of E and J is a group which forms a benzene ring or a pyridine ring via a double bond; R<6> and R<7> is independently a hydrogen atom or a lower alkyl or the like specified substituent.
Patent DE-69833324-T2 (DE)
Inventor: HARLIN ALI
IPC: C08F210/06
Filed: 1998-06-24
Granted: 2006-09-21
Abstract: Described herein is a process and an apparatus for polymerizing propylene. The process comprises carrying out the polymerization in at least one slurry reactor and at least one gas phase reactor without recycling unreacted monomers to the slurry reactor. A polymerization product containing unreacted monomers is recovered from the slurry reactor and volatile components are separated from the product in a separation unit. The polymerization product is recovered from the separation unit and conducted to a first gas phase reactor; and at least a part of the volatile components a recovered from the separation unit and conducted them to a gas phase reactor. At least 10% of the polymer product is produced in the gas phase reactor(s). The invention provides propylene homopolymers and alloys of propylene homopolymers and copolymers having good impact and creep properties.
Patent DE-69833629-T2 (DE)
Inventor: PONCELET PHILIPPE
IPC: C12N5/078
Filed: 1998-06-08
Granted: 2006-12-21
Abstract: Separation of platelets (or micro-particles of platelet origin) from a sample involves: (a) centrifuging the sample in a container having at its distal end a compact gel (I) which is impermeable to the liquid of the sample but is penetrated by the platelets or micro-particles under the centrifugation conditions; (b) optionally separating the centrifugation supernatant; and (c) recovering the platelets or micro-particles incorporated in (I).
Patent DE-69900899-T2 (DE)
Inventor: ASGHAR SYED ALI
IPC: B65G33/06
Filed: 1999-09-16
Granted: 2002-11-28
Abstract: In a device for feeding articles (21), cylindrical feed screws (35,36) having left and right hand pitched helical grooves (34,37) are arranged in parallel and are driven rotationally in opposite directions such that an article (21) deposited in the space between the roots of the grooves (34,37) at one corresponding end of the grooves (34,37) will be advanced axially to the opposite ends for exiting from between the feed screws (35,36). <IMAGE>
Patent DE-69901810-T2 (DE)
Inventor: POSTMUS JOZEF
IPC: H01H5/04
Filed: 1999-03-24
Granted: 2003-01-09
Abstract: A switch includes two interacting contacts (1, 2) and a closing spring (5, 11, 15, 21) for moving the contacts into the closed position, an operating button which can be used to initiate a prestressing phase of the closing spring (5, 11, 15, 21), and a locking device (6) for locking the contacts (1, 2) until a predetermined moment at which the influence of the prestressed closing spring (5, 11, 15, 21) is to be released onto the contacts. The locking device (6) is designated to lock the interacting contacts (1, 2), during the prestressing phase, at a contact distance. The contact distance to be locked being less than the contact distance in the open position of the contacts (1, 2).
Patent DE-69902673-T2 (DE)
Inventor: MCHALE CHRISTOPHER
IPC: A01F15/07
Filed: 1999-09-22
Granted: 2003-04-24
Abstract: A bale wrapper (1) for wrapping a round bale (2) comprises a holder (15) for supporting a roll of plastics film material for wrapping the bale. The holder (15) comprises an upstanding support member (17) from which lower and upper carrier arms (18) and (21) extend for carrying a fixed lower first spigot (19) and a slidable upper second spigot (22). A retaining pin (32) is engageable with a groove (38) in the second spigot (22) for retaining the second spigot (22) in a cocked position for facilitating replacement of a spent roll (4) with a replacement roll. A pull cord (39) connected to the retaining pin (32) releases the retaining pin (32) for releasing the second spigot (22) from the cocked position. A spent roll (4) is removed from the holder (15) by manually urging the empty reel (20) upwardly against the second spigot (22) for urging the second spigot (22) into the cocked position where it is retained by the retaining pin (32). The spent reel is then removed. A new roll placed on the first spigot (19) is aligned with the second spigot (22), which is released. The pull cord (39) is pulled from the cocked position by the pull cord (39) for engaging the new roll (4).
Patent DE-69904858-T2 (DE)
Inventor: DUBOIS JEAN-MARIE
IPC: B01J37/03
Filed: 1999-10-18
Granted: 2003-11-06
Abstract: A material composed of ultrafine particles, comprising at least a metal element M having catalytic properties and at least a metal element M' having a standard oxidation potential less than that of M, part at least of M' atoms being in oxidized form, the average size of the particles being less than 50 nm, at least 80% in number of the particles having an average size less than 10 nm. One particle of the material is constituted by at least a metal element M with oxidation level 0, or by at least a metal element M' in oxidized form, or by at least a metal element M' with oxidation level 0, or by the combination of at least two species selected from the three previous species. The material is useful as a catalyst for hydrogenation or coupling reactions.
Patent DE-69915473-T2 (DE)
Inventor: PIRENEI ALESSANDRO
IPC: B65G47/82
Filed: 1999-09-22
Granted: 2005-03-10
Abstract: Herein described is a method for the planar transfer of groups of products in general, from a first (S) to a substantially coplanar second (A) position, without altering the original configuration-arrangement of the said groups, where the formation of a rigid cast for each group G present in the first position (S) takes place, followed by planar transfer of this rigid cast to the other position (A), where the products are then released. <IMAGE>
Patent DE-69915973-T2 (DE)
Inventor: SHIMIZU SHINGO
IPC: G07F17/32
Filed: 1999-11-01
Granted: 2005-03-10
Abstract: In a gaming machine which has a display arrangement for displaying symbols related to a game, the display arrangement includes a display screen (2a) that indicates symbols including special symbols (20L, 20C, 20R) for showing transfer to special game state when varying special symbols stop to produce a predetermined stop pattern, and predictive symbols (21L, 21C, 21R) for predicting appearance of the stop pattern. The display screen (2a) indicates not only the symbols but also commentary information of game. <IMAGE>
Patent DE-69924583-T2 (DE)
Inventor: JUMAN MOHAMAD IKE
IPC: A61F2/06
Filed: 1999-11-15
Granted: 2006-03-02
Abstract: A balloon catheter and stent delivery system for medical treatment of a patient includes a balloon inflatable to an inflated shape having a cylindrical working portion, and a deflated shape that is temporarily reformed to enhance longitudinal retention of the stent while the catheter system is advanced or withdrawn. The balloon catheter provides for uniform expansion of the stent when the balloon is inflated. In addition, the balloon catheter system can be modified to initiate partial inflation of the proximal and distal ends of the stent, to further resist longitudinal motion of the stent during inflation, and to facilitate more effective tacking of the stent. One possible feature of the catheter system is that the balloon is pleated in a particular pattern when deflated, whereby the central balloon portion carrying the stent has a greater number of pleats than the pillow portions proximal and distal of the stent. Another possible feature is the formation of small channels that facilitate fluid communication from the proximal end of the balloon to the distal end, even when the balloon is deflated. The balloon may be formed to protrude partially outward among the stent interstices while in its deflated state, further enhancing stent position retention. The present invention also protects the leading or distal end of the stent during advancement, and protects the proximal end of the stent during any withdrawal of the catheter system.
Patent DE-69925618-T2 (DE)
Inventor: HOON DAVE
IPC: A61K9/127
Filed: 1999-04-05
Granted: 2006-04-27
Abstract: RNA cancer vaccines and methods for their use are described. The vaccines are comprised of viral liposomes comprising nucleic acid, preferably RNA, encoding a tumor-associated antigen. The viral liposomes may be formed by the fusion of HVJ reagents with nonviral reagents. The vaccine may be administered subcutaneously, intradermally, intramuscularly or into an organ. The vaccine may be administered to induce a host normal cell to express the tumor associated antigen.
Patent DE-69926970-T2 (DE)
Inventor: RAM PRASAD
IPC: G06F21/62
Filed: 1999-10-22
Granted: 2006-02-23
Abstract: A system and method for the secure distribution of electronic documents reduces the likelihood of unauthorized reproduction and redistribution by either authorized or unauthorized recipients. A self-protecting document (SPD) contains an encrypted document as well as a secure set of permissions and the software necessary to process the document; full decryption of the document is performed as late as possible so as to minimize the possibility of intercepting the document before it has been fully rendered to screen or to paper.
Patent DE-69934538-T2 (DE)
Inventor: FABRIZI FABRIZIO
IPC: H01H71/46
Filed: 1999-04-14
Granted: 2007-10-04
Abstract: A power switch (10) and a differential module (11) are mounted side by side on a common support (12) and are connected to one another electrically by substantially rigid metal strips (21) which extend, for part of their length, through a passageway (20) delimited by the adjacent sides of the two devices. <IMAGE>
Patent DE-69935992-T2 (DE)
Inventor: SIKORSKI JAMES A
IPC: C07C291/04
Filed: 1999-09-23
Granted: 2008-01-10
Abstract: The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Novel high yield, stereoselective processes for the preparation of the chiral substituted alkanol compounds from chiral and achiral intermediates are described.
Patent DE-69936545-T2 (DE)
Inventor: HINOKI NAMI
IPC: A61F13/53
Filed: 1999-12-22
Granted: 2007-11-22
Abstract: An improved absorbent article is disclosed. The absorbent article has a longitudinal centerline and a lateral centerline, and comprises a topsheet, a backsheet, and an absorbent component. The topsheet has a topsheet opening. The absorbent component comprises a storage member and a distribution member. The storage member has a storage member opening surrounded by a periphery edge. The distribution member comprises an acquisition portion and a main portion wherein. The main portion extends underneath the storage member. The acquisition portion protrudes through the topsheet opening and the storage member opening, and extends over the topsheet longitudinally outwardly or laterally outwardly beyond the periphery edge of the storage member opening.
Patent HU-E031037-T2 (HU)
Title: Human monoclonal antibody human cd134 (ox40) and methods of making and using same
Inventor: KATO SHINICHIRO
IPC: C12N15/13
Filed: 2006-11-27
Abstract: The invention provides antibodies that specifically bind to OX40 (CD 134), referred to as OX40 antibodies, anti-OX40 or anti-OX40 antibodies. Invention antibodies that specifically bind to OX40 include mammalian (human, primate, etc.), humanized and chimeric anti-OX40 antibodies. Invention antibodies and antibody subsequences (fragments) that specifically bind to OX40 include purified and isolated antibodies, as well as pharmaceutical formulations thereof, are useful in various methods including treatment, screening and detection methods.
Patent HU-E035789-T2 (HU)
Title: Methods and apparatus for subframe interlacing in heterogeneous networks
Inventor: DAMNJANOVIC ALEKSANDAR
IPC: H04W72/04
Filed: 2010-09-15
Abstract: Methods and apparatus for providing wireless communications using subframe partitioning are disclosed. Two or more base stations may be allocated subframes in a radio frame. All or part of the subframe allocation may be provided to the associated user equipment (UEs), which may use it to determine signal metrics during assigned subframes for an associated base station.
Patent HU-E028233-T2 (HU)
Title: Process for preparing oxycodone hydrochloride compositions having less than 25ppm 14-hydroxycodeinone
Inventor: CHAPMAN ROBERT
IPC: C07D489/08
Filed: 2005-03-30
Abstract: In certain embodiments the invention is directed to a pharmaceutical dosage form comprising an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
Patent MD-3204025-T2 (MD)
Inventor: GRANT GEORGE
IPC: C12N1/20
Filed: 2016-06-15
Abstract: Invenţia furnizează compoziţii conţinând tulpini bacteriene pentru tratarea şi prevenirea bolilor inflamatorii şi autoimune.